GMR Data's new Pharmaceutical report is released today detailing The Brazil, Russia, India and China Over-the-Counter Pharmaceuticals Market to 2025. The report draws on knowledge of experts in the field, in depth company research and up to date tracking of trends in the OTC sector.
By exploring and comparing these key 4 markets GMR Data aim to give the reader the best indication of how these markets will progress to 2025; which OTC areas will offer the most growth and what location specific issues any entrant to the respective OTC markets can face.
In this brand new 126-page report you will receive 70 tables and 35 figures - all unavailable elsewhere. By ordering and reading our brand new report today you stay better informed and ready to act.
The report provides clear detailed insight into the BRIC OTC. Discover the key drivers and challenges affecting the market.
Drivers include
- Growing awareness of OTC products amongst consumers
- Increasing purchasing power parity of the consumers
- Increasing NCD population will drive OTC demand in BRIC nations
Restraints include
- Stringent regulations
- Infrastructural Challenges - distribution networks
The income disparity in emerging BRIC countries is comparatively high when compared to developed nations. This is the fundamental challenge faced by multinationals operating in these markets. Whereas growing populations and increasing consumer awareness for self-medication are important factors driving the demand.
GMR Data's The Brazil, Russia, India and China Over-the-Counter Pharmaceuticals Market to 2025 also benefits from 3 exclusive interviews with representatives from;
- Novartis
- Ranbaxy
- Sanofi
These leading, in the field, experts offer exclusive insight into the BRIC OTC sector; how they see the market currently, which geographical areas will witness growth and which sub sectors / OTC drugs face perhaps face an uncertain growth trajectory.
With the growing economies of the BRIC countries, the purchasing power of the general population is increasing, which in turn increases the market size for OTC products.
The BRIC OTC Market to 2025
Table of Contents
The Brazil, Russia, India & China Over-the-Counter Pharmaceutical Market to 2025
1 - Executive Summary
1.1 Executive Summary
1.2 Research and Analysis Methods
1.3 Drivers & Restraints of the BRIC OTC Market to 2025
1.3.1 Drivers
1.3.1.1 Growing awareness of OTC products amongst consumers
1.3.1.2 Increasing purchasing power parity of the consumers
1.3.1.3 Increasing elderly, smoking and obese population to drive OTC demand in BRIC
1.3.1.4 Favourable government regulations and promotion of OTC products in emerging markets
1.3.2 Restraints
1.3.2.1 Stringent regulatory actions
1.3.2.2 Infrastructural Challenges
2 - Introduction to the BRIC OTC Market to 2025
2.1 OTC Pharmaceuticals
2.1.1 Classification of OTC Pharmaceuticals in BRIC Nations
2.2 Market Segmentation of OTC Pharmaceuticals
3 - The BRIC OTC Market to 2025
3.1 Global OTC Pharmaceutical Market to 2025
3.2 Breakdown by OTC Segment, Globally, 2014 - 2025
3.3 BRIC OTC Pharmaceuticals Market Overview
3.3.1 Economic Indicators, BRIC Countries, 2013
3.4 BRIC OTC Pharmaceuticals Market, 2013-2025
3.4 The Brazil OTC Pharmaceuticals Market Overview to 2025
3.4.1 Overview of Brazil
3.4.2 Brazil OTC Pharmaceuticals Market, 2014-2025
3.4.3 Breakdown by Segment, Brazil, 2014 and 2025
3.4.3.1 Skin Care
3.4.3.2 CC&A
3.4.3.3 Analgesics
3.4.3.4 Vitamins, Minerals & Supplements (VM&S)
3.5 Drivers for OTC Pharmaceuticals Growth, Brazil
3.5.1 Expansion of distribution channels
3.5.2 Favourable government regulations for OTC
3.5.3 Affordability of OTC products
3.5.4 Increasing middle class
3.5.5 Increase in non-communicable disease
3.5.6 OTC Companies in Brazil
3.5.6.1 Aché Laboratórios Farmacêuticos
3.5.6.2 Hypermarcas
3.5.6.4 EMS
3.5.6.5 Apsen Farmacêutica
3.6 The Russia OTC Pharmaceuticals Market Overview, to 2025
3.6.1 Overview of Russia
3.6.2 Russia OTC Pharmaceuticals Market, 2013-2025
3.6.3 Breakdown By Segment, Russia
3.6.3.1 CC&A
3.6.3.2 Digestives
3.6.3.3 Analgesics
3.6.4 Key Domestic Companies in the Russian OTC Market
3.6.4.1 Pharmstandard JSC
3.6.5 Regulatory Environment, Russia
3.6.6 Drivers for OTC Pharmaceuticals Growth, Russia
3.6.6.1 Growing popularity of direct and online sales channels
3.6.6.2 Growing disposable income
3.6.6.3 Growing incidence of non-communicable diseases
3.7 The India OTC Market Overview, to 2025
3.7.1 Overview of India
3.7.2 India OTC Pharmaceuticals Market to 2025
3.7.3 Breakdown by Segment, India, 2013 and 2025
3.7.3.1 VM&S
3.7.3.2 Cough and Cold
3.7.3.3 Analgesics
3.7.4 Regulatory Environment, India
3.7.5 Drivers for OTC Pharmaceuticals Growth, India
3.7.5.1 Consumer behaviour
3.7.5.2 Wide distribution
3.7.5.3 Liberal regulatory procedures
3.7.5.4 Availability of OTC Products
3.7.5.5 Margins on OTC Products
3.8 The China OTC Market Overview to 2025
3.8.1 Overview of China
3.8.2 China OTC Pharmaceuticals Market to 2025
3.8.2.1 Cough, Cold & Allergy
3.8.2.2 VM&S
3.8.2.3 Analgesics
3.8.3 Breakdown by Segment, China, 2013 and 2025
3.8.4 Regulatory Environment, China
3.8.5 Drivers for OTC Pharmaceuticals Growth, China
3.8.5.1 Economic performance
3.8.5.2 Increase in smoking / obese population
3.8.5.3 Increase in the elderly population
3.8.5.4 Growth in consumer awareness and self-medication
4 - Leading companies in the BRIC OTC Market
4.1 Leading companies in the BRIC OTC Market
4.2 Bayer
4.2.1 Bayer's Company Overview
4.2.2 Bayer's Key OTC Products
4.2.3 Bayer's Financial Performance
4.2.4 BRIC Developments from Bayer
4.3 Boehringer Ingelheim
4.3.1 Boehringer Ingelheim's Company Overview
4.3.2 Boehringer Ingelheim's Key OTC Products
4.3.3 Boehringer Ingelheim's Financial Performance
4.3.4 BRIC Developments from Boehringer Ingelheim
4.4 GlaxoSmithKline (GSK)
4.4.1 GSK's Company Overview
4.4.2 GSK Key OTC Products
4.4.3 GSK's Financial Performance
4.4.4 BRIC Developments from GSK
4.5 Johnson & Johnson
4.5.1 Johnson & Johnson Company Overview
4.5.2 Johnson & Johnson Key OTC Products
4.5.3 Johnson & Johnson Financial Performance
4.5.4 BRIC Developments from Johnson & Johnson
4.6 Merck
4.6.1 Merck's Company Overview
4.6.2 Merck's Financial Performance
4.6.3 BRIC Developments from Merck
4.7 Novartis
4.7.1 Novartis's Company Overview
4.7.2 Novartis Key OTC Products
4.7.3 Novartis's Financial Performance
4.7.4 Recent BRIC Developments from Novartis
4.8 Perrigo
4.8.1 Perrigo's Company Overview
4.8.2 Perrigo Key OTC Products
4.8.3 Perrigo's Financial Performance
4.8.4 Recent BRIC Developments from Perrigo
4.9 Pfizer
4.9.1 Pfizer's Company Overview
4.9.2 Pfizer Key OTC Products
4.9.3 Pfizer's Financial Performance
4.9.4 Recent BRIC Developments from Pfizer
4.10 Procter & Gamble
4.10.1 Proctor & Gamble Company Overview
4.10.2 Proctor & Gamble Key OTC Products
4.10.3 Proctor & Gamble Financial Performance
4.10.4 Recent BRIC Developments from Procter & Gamble
4.11 Reckitt-Benckiser
4.11.1 Reckitt-Benckiser Company Overview
4.11.2 Reckitt-Benckiser Key OTC Products
4.11.3 Reckitt Benckiser's Financial Performance
4.11.4 Recent Developments from Reckitt Benckiser
4.12 Sanofi
4.12.1 Sanofi's Company Overview and Key products
4.12.2 Sanofi's Key OTC Products
4.12.3 Sanofi's Financial Performance
4.12.4 Recent Developments from Sanofi
5- SWOT Analysis of the BRIC OTC Market to 2025
5.1 SWOT Analysis
5.1.1 Strengths:
5.1.1.1 Regulators are encouraging OTC approvals
5.1.1.2 Strong potential of OTC portfolio
5.1.1.3 Economic Advantages
5.1.1.4 Growing consumer awareness and self-medication
5.1.1.5 Increased purchasing power in emerging markets
5.1.2 Weaknesses
5.1.2.1 High focus on prescription and generic drugs
5.1.2.2 OTC products are vulnerable to price fluctuations
5.1.2.3 Inadequate Investment in infrastructure
5.1.2.4 Lack of proper health insurance system in BRIC
5.1.2.5 Income disparity
5.1.2.6 Distribution network
5.1.3 Opportunities
5.1.3.1 Increase in the Number of Self-administering Patients
5.1.3.2 Opportunities in social media and online marketing
5.1.3.3 Strong growth in the emerging / BRIC markets
5.1.3.4 Demographic changes
5.1.3.5 Growing health problems such as smoking and obese population
5.1.3.6 Improving the healthcare system
5.1.4 Threats:
5.1.4.1 Resistance to OTC switching for some groups (CNS, CVS)
5.1.4.2 Competition from private label brands will reduce profits
5.1.4.3 Regulatory concerns
6- Expert Opinion
6.1 Novartis
6.2 Ranbaxy
6.3 Sanofi
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
